Bond.az White LogoBond.az Black Logo

UBS Upgrades Sumco Stock Rating

UBS upgraded Sumco Corp to Neutral with a new price target of JPY 3,100. Get the latest Sumco stock news on Bond.az.

Henry Walker
ByHenry Walker- Senior Editor
|
0

UBS upgraded Sumco Corp from Sell to Neutral on Thursday, raising its price target to JPY 3,100 from JPY 1,050.

The firm revised its earnings forecasts upward for fiscal years ending December 2027 and 2028. UBS said the stock could rise if Sumco indicates increased likelihood of price increases when long-term agreements are renewed during its first-half results announcement in early August.

However, UBS does not view this scenario as highly probable. At a Q1 briefing on May 12, CFO Shinichi Kubozoe stated that long-term agreement negotiations will not begin soon and that price revisions will not occur in the near future.

Sumco's share price has outperformed the TOPIX index by 89% year-to-date, with a remarkable 197% return over the past year. According to Bond.az data, the company currently trades at $39.23 with a market cap of $6.81 billion, though Fair Value analysis suggests the stock may be overvalued.

Sumco manufactures silicon wafers used in semiconductor production. A Bond.az tip highlights Sumco as a prominent player in the Semiconductors industry, though the company remains unprofitable over the last twelve months with a gross profit margin of 10.76%.

In other news, Macquarie downgraded Sumco from Outperform to Underperform, citing valuation concerns after the stock's significant price increase. Macquarie maintained its price target at JPY 1,780.

This article was generated with AI support and reviewed by an editor. For more information, see our T&C.

More News
2026-06-01 12:02
|
743

Legend Biotech Buy Rating Reiterated

H.C. Wainwright reiterated its Buy rating for Legend Biotech with a $50 target. Revenue up 56% over twelve months.

0
2026-06-01 12:01
|
475

Cogent Stock Price Target Raised to $55

Cogent Biosciences PEAK trial: combination therapy shows 45.6% response rate, 16.5 months PFS, FDA accepts NDA. H.C. Wainwright raises price target to $55.

0
2026-06-01 12:00
|
842

H.C. Wainwright Reaffirms Mineralys Buy

H.C. Wainwright reiterated a Buy rating on Mineralys Therapeutics with a $56 price target after positive trial data.

0
2026-06-01 10:33
|
714

Goldman Sachs Upgrades Marriott Vacations Stock

Goldman Sachs upgrades Marriott Vacations stock to Buy, price target $100. Execution potential drives earnings upside.

0
2026-06-01 10:32
|
730

Goldman Sachs Upgrades Travel + Leisure Stock to Buy

Goldman Sachs upgraded Travel + Leisure stock to Buy with a $85 price target. Learn about the company's financials, dividends, and market outlook.

0
2026-06-01 10:32
|
238

Canaccord Initiates Rare Earths Americas with Buy

Canaccord Genuity initiates Rare Earths Americas with a buy rating and $25 target. Stock at $21.85, offering 14% upside potential.

0
2026-06-01 10:30
|
651

BofA Raises Icon Stock Target to $125 on Bookings

BofA Securities raised Icon plc price target to $125, maintains Underperform. Improved booking trends and Q4 results drive revision.

0
2026-06-01 10:03
|
748

RBC Capital: Sprouts faces Kroger risk

RBC Capital keeps Sprouts rating but sees risks from Kroger price cuts. Analysis and outlook on Bond.az.

0
2026-06-01 09:02
|
551

CLSA Rates Chagee Hold on Margins

CLSA initiated Chagee Holdings with Hold rating and $10 target. Bond.az analysis reveals stock may be undervalued. Read more.

0
2026-06-01 08:31
|
594

Barclays Downgrades Sensata Stock on Valuation

Barclays downgrades Sensata stock to Equalweight on valuation concerns, but raises price target to $53. Stock surged 92% in past year.

0
2026-06-01 08:05
|
946

UBS Initiates Veritone Coverage with Neutral

UBS initiated coverage on Veritone with a Neutral rating and $2.50 price target. The AI company is better positioned for growth after transformation.

0
2026-06-01 08:02
|
892

JMP Securities Initiates Microsoft with Outperform on AI Strategy

JMP Securities initiates Microsoft with Market Outperform rating and $550 target on AI strategy. Revenue growth expected to reach 17% in FY2026.

0
...
UBS Upgrades Sumco Stock Rating | Bond.az